The International Journal of Frontier Sciences agrees to accept manuscripts prepared in accordance with the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Journals.
Manuscripts are accepted for consideration if neither the article nor any of its contents has been or will be published or submitted elsewhere before appearing in The International Journal of Frontier Sciences. Authors will have to register their account on www.tijfs.com and submit their manuscript through that account. A brief tutorial for manuscript submission can be found on the journal website.
Authors are required to submit an undertaking signed by all the authors, (certifying originality of work and that the article has not been or will not be published elsewhere, and transfer of copyrights to TIJFS). Specimen for the undertaking is available online (www.tijfs.com). No more than 12 names will be listed under the title; other names will appear in a footnote.
Research and Publication Ethics: The authors must declare approval of the ‘Research Ethics Committee’ and clearly mention any ‘Conflict of Interest, Statement of Informed Consent and Statement of Human and Animal Rights’ either in the script or attached document.
Abstracts: Abstract should not exceed more than 250 words. This abstract should be structured under the following headings: Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results.
Keywords: Three to 10 keywords or short phrases should be added to the bottom of the abstract page.
The original article should be structured under the following headings: Introduction, Material & Methods, Results, Discussion, Conclusions, Acknowledgements and References.
Short report of cases, clinical experience, drug trials or adverse effects may be submitted. They must not exceed 500 words, 5 bibliographic references and one table or illustration. The report must contain genuinely new information. The format is Title, Abstract, Introduction, Case Report, Discussion, and References.
Review Article, Editorial, Special Communication, Short Communication and Pictorial can also be submitted. All these should be submitted along with brief abstracts not exceeding 250 words.
References should all start on a separate page from page 3 onwards.
References: The total number of references in an Original Article must not exceed 40, while in the Review Articles maximum limit of references is 100. References must be written single-spaced and numbered as they are cited in the text. The references must be written in Vancouver style. List all authors when they are six or fewer. If they are seven or more, list the first six followed by ‘et al’. Following are examples of reference citation:
Journal Article: Ashraf T, Yousaf K, Karim MT. Early experience of endovascular treatment of peripheral vascular disease. J Ayub Med Coll Abbottabad 2015;27(1):93–6.
Books: Polit DF, Hungler BP. Nursing research principles and methods. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 1999.
Chapter in Book: Woessner JF. Lysosomal function. In: Dingle JT, Fell HG, editors. Lysoosomes, in biology and pathology. London: North Holland Publishing Co; 1969:299–329.
Tables and Illustrations: Tables and figures should be submitted separately as guided in the automated submission software and must have a title, and be on double space. Figures should be professionally designed. Symbols, lettering, and numbering should be clear and large enough to remain legible after the figure has been reduced to fit the width of a single column of 3 inch. If photographs of patients are used, either the subjects should not be identifiable or their pictures must be accompanied by written permission to publish the picture. Duplication of results given in tables and figures must be avoided.
Units of Measurement: All measurements should be expressed in conventional units, with System International (SI) units given in parentheses throughout the text.
Abbreviations: Except for units of measurement, abbreviations are discouraged. The first time an abbreviation appears it should be preceded by the words for which it stands, However, title and abstract must not contain any abbreviations.
Names of Drugs: Brand names of drugs are not permitted. Only generic names of drugs should be used.
Permissions: Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the Journal for reproduction.
Review and Processing: An acknowledgment is issued on receipt of the manuscript. The manuscripts are examined by the editors and then sent for peer review. The comments of reviewers are then conveyed to the corresponding author. After correction/amendments by the authors, acceptance letter for accepted article is issued, and the article is placed in queue for printing.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission’s compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
Name ,email ,affiliation and reviewing interest of two reviewers have been uploaded as a supplementary file.
The metadata for the author and all the co-authors is complete.
There is no information about the author or co author in the main manuscript file uploaded for review as a review file.
The author agrees that if the manuscript is accepted for publication he/she is bound to pay the publication fee.
The author agrees to transfer the copy rights of the article to TIJFS.
The author and co authors certifies that the manuscript has neither been published nor submitted in any other journal for publication.
All the references are written in vancouver style.
The manuscript has been prepared in MS word.With font size 10,style:Times new roman and single spaced.
Once submitted there will be no change in author and co author names and order.Any such requests may lead to rejection of manuscript.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.